The Effectiveness of Idazoxan in Treating TRD
Phase 3
Withdrawn
- Conditions
- Major Depressive Disorder
- Registration Number
- NCT00294944
- Lead Sponsor
- Sheba Medical Center
- Brief Summary
Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- MDD patients
- Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose
- In or out patients
Exclusion Criteria
- Psychotic symptoms
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chaim Sheba Medical Center
🇮🇱Ramat-Gan, Israel